Understand the complete disease landscape and size global markets with real-world data.
165+ Diseases & Biomarkers | 45 Countries | 3,500+ Patient Segments
Get to a deeper level of understanding with DRG Epidemiology.
- Extensive insights of oncology populations by stage, line of therapy, and biomarker
- Expanding rare and niche disease coverage
- Highest-profile disease coverage with ~90% of the global population
- Growing emerging market coverage across all regions
- Bottom-up patient-level forecasts
- Rigorous methodology refined over two decades
Our industry-leading experts are available for ad-hoc projects and on-site support.
- Comprehensive literature review
- Cancer progression modeling and eligible patient sizing
- Market sizing for complex indications
- Rare disease epidemiology
- Pharmacovigilance/drug safety
- Customized patient flows
- Corporate strategy and pipeline evaluation
- Budget impact analysis
- Sub-national US population sizing
Contact us today to learn how DRG can help you unlock hidden potential with Epidemiology.